4//SEC Filing
Anderson Cynthia Lynn 4
Accession 0001415889-23-012532
CIK 0001411685other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 1:09 PM ET
Size
5.9 KB
Accession
0001415889-23-012532
Insider Transaction Report
Form 4
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-08-21+8,333→ 8,333 totalExercise: $5.34Exp: 2033-08-21→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]25% of the stock options vest on August 21, 2024 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
- [F2]The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.
Documents
Issuer
Vistagen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001989905
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 1:09 PM ET
- Size
- 5.9 KB